NCT03270241View on ClinicalTrials.gov

Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

March 14, 2023

Study Completion Date

March 14, 2023

Conditions
VitiligoDermatology/Skin - Other
Interventions
DEVICE

Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet

This is an investigator-initiated, single-blinded, ascending dose study of NB-UVB treatment for Vitiligo in adults of 3 treatments for one week. It is designed to measure the molecular changes and re-pigmentation in affected and normal skin of participants with Vitiligo and normal skin in healthy participants.

Trial Locations (1)

21287

Johns Hopkins Outpatient Center, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT03270241 - Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy | Biotech Hunter | Biotech Hunter